CONGRESS 2023 - Myeloma screening – Best practice and new developments

Myeloma screening is a high volume investigation pathway, performed by both Biochemsitry and Immunology laboratories. National audit data has shown there to be high variation between laboratories on the implementation of this workflow, leading to potentially inconsistent patient care geographically. This talk will aim to cover the following areas: Give brief foundation knowledge on serum electrophoresis/immunodisplacement/immunofixation Introduce the Myeloma UK Best practice guidelines for Myeloma screening Discuss Mass spec methods for analysing monoclonal protein Discuss monitoring of myeloma patients and monitoring of Monoclonal gammopathy of undetermined significance (MGUS) patients.

Download as vCalendar (for Microsoft Outlook etc.)

Import event to your Google Calendar